A 0.1% propanetriol-triaconitine suspension, its preparation method and application

By treating propionyl brassinolide and triacontanol with co-crystallization and microencapsulation technologies, the problems of low stability and low bioavailability of suspension concentrates were solved, achieving efficient extension of efficacy and shelf life.

CN123100627APending Publication Date: 2026-11-17JIANGXI XINBANG BIOCHEMICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611448779.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-17
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing propionyl brassinolide and triacontanol suspensions suffer from poor storage stability and low bioavailability. In particular, the active ingredients are insoluble in water and easily affected by light and heat, leading to uneven distribution and degradation.

Method used

A co-crystallization technique was used to form a co-crystallization of propionyl brassinolide and nicotinamide. Combined with microencapsulation technology, a 0.1% propionyl brassinolide-triacontanol suspension was prepared. The co-crystallization technique was used to lock the acyl fragments to reduce photothermal sensitivity. Microcapsules were formed by interfacial polymerization to achieve uniform mixing and protect the active ingredients.

Benefits of technology

It significantly improves the stability and bioavailability of suspensions, prolongs the duration of efficacy and shelf life, enhances the physical and chemical stability of active ingredients, and avoids decomposition and stratification.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_4
    Figure SMS_4
Patent Text Reader

Abstract

This invention discloses a 0.1% propargyl brassinolide·triacontanol suspension, its preparation method, and its application, belonging to the field of pesticide formulation technology. The propargyl brassinolide·triacontanol suspension, based on 100 parts by weight, comprises 0.09-0.11 parts of the active ingredient, 1.5-2.5 parts of emulsifier, 6-10 parts of dispersant, 0.1-0.3 parts of thickener, 0.1-0.3 parts of preservative, 0.04-0.1 parts of adjuvant, and the balance being diluent; wherein the active ingredient is propargyl brassinolide·triacontanol, prepared from co-crystal propionyl brassinolide and triacontanol at a mass ratio of (2-5):(95-98). This propargyl brassinolide·triacontanol suspension fully utilizes the complementary properties of propionyl brassinolide and triacontanol, not only improving efficacy but also significantly extending the duration of efficacy and effective storage period, ultimately achieving dual physical and chemical stability, and can be widely applied to the cultivation of fruits, field crops, and cash crops.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of pesticide formulation technology, specifically relating to a 0.1% propargyl triacontanol suspension, its preparation method, and its application. Background Technology

[0002] Propionyl brassinolide is a broad-spectrum, highly active plant growth regulator that acts directly on crops by balancing or regulating the secretion of other endogenous hormones, such as promoting growth (directly acting and promoting auxin synthesis and secretion), promoting flowering (directly acting and promoting gibberellin and cytokinin synthesis and secretion), and promoting fruit enlargement (directly acting and promoting cytokinin and ethylene synthesis and secretion). Triacontanol, a long-chain fatty alcohol, is also a highly effective and low-toxicity plant growth regulator. It mainly works by enhancing the activity of various enzymes, such as polyphenol oxidase, improving cell permeability, increasing chlorophyll content, and enhancing photosynthesis and assimilation. Propionyl brassinolide focuses on long-term effects and regulating endogenous hormone balance to enhance stress resistance, while triacontanol focuses on activating metabolic enzyme activity and promoting substance accumulation. The combination of the two has a good effect on stress resistance and yield increase, and is widely used in grains, oilseeds, fruits, vegetables, and cash crops.

[0003] Currently, there are many compound formulations of propionyl brassinolide and triacontanol in the field, such as propionyl brassinolide-triacontanol suspension and propionyl brassinolide-triacontanol seed treatment liquid. However, due to limitations in the characteristics of the active ingredients and formulation technology, some formulations still have certain shortcomings in application. Taking suspensions as an example, since both propionyl brassinolide and triacontanol are insoluble in water, and propionyl brassinolide is sensitive to light and heat and easily degraded, while triacontanol tends to concentrate and result in uneven distribution, the formulation has poor storage stability and insufficient bioavailability.

[0004] Therefore, it is of great significance to research and develop a compound preparation of propargyl triacontanol with stable active ingredients, high bioavailability, and long shelf life. Summary of the Invention

[0005] In view of the problems mentioned in the background art, the purpose of this invention is to provide a 0.1% propanetriol-triacontanol suspension, its preparation method and application. This propanetriol-triacontanol suspension has high activity and good enhancement effect, while also exhibiting excellent stability and long shelf life, overcoming the defects of traditional suspensions and meeting the application needs of more scenarios.

[0006] To achieve the above objectives, the present invention specifically adopts the following technical solution: This invention provides a 0.1% propanetriol-triaconitine suspension, which, based on 100 parts by weight, comprises the following raw materials: 0.09-0.11 parts of technical grade drug, 1.5-2.5 parts of emulsifier, 6-10 parts of dispersant, 0.1-0.3 parts of thickener, 0.1-0.3 parts of preservative, 0.04-0.1 parts of adjuvant, and the balance is diluent; The active ingredient is propionyl brassinolide and triacontanol, specifically prepared by cocrystallized propionyl brassinolide and triacontanol in a mass ratio of (2-5):(95-98).

[0007] Furthermore, the cocrystallized propionyl brassinolide uses nicotinamide as the cocrystallized ligand; the cocrystallization preparation method is as follows: dissolve propionyl brassinolide and nicotinamide in anhydrous ethanol, heat and stir until homogeneous, then cool and crystallize to obtain a solid, wash and dry to obtain cocrystallized propionyl brassinolide.

[0008] Furthermore, the mass ratio of propionyl brassinolide to nicotinamide is 1:(1.2-1.5); the heating and stirring temperature is 30-35℃, the stirring speed is 300-500 rpm, and the time is 10-20 min; the cooling and crystallization temperature is 10-12℃.

[0009] To address the photosensitive and easily decomposed nature of propionyl brassinolide, this invention employs nicotinamide to co-crystallize it. After co-crystallization, the acyl fragments of propionyl brassinolide are locked within the crystal lattice, reducing direct contact with moisture and light, thereby mitigating its photosensitivity and hydrolysis tendency. Furthermore, the co-crystallized propionyl brassinolide exhibits more uniform dispersion in the oil phase of the encapsulation material, which is beneficial for subsequent preparation of homogeneous microcapsules with triacontanol.

[0010] Furthermore, the propanetriol-triacontanol microcapsules need to be prepared in advance: according to the formula, co-crystalline propionyl brassinolide and triacontanol are weighed, mixed with polyisocyanate, added to a solvent, heated and stirred evenly to form the oil phase; separately, emulsifier, dispersant, polyvinyl alcohol, and chitosan oligosaccharide are added to water in sequence and stirred evenly to form the aqueous phase; the oil phase is slowly dripped into the aqueous phase and emulsified by high-speed shearing to obtain the primary emulsion; diethylenetriamine is slowly added to the primary emulsion, polymerization is carried out under controlled temperature, the reaction is completed and solidified, and the microcapsules of propanetriol-triacontanol are obtained by separation, washing and drying.

[0011] Furthermore, the amount of each raw material in the microcapsule is as follows by weight: 1 part of cocrystallized brassinolide and triacontanol, 8-10 parts of polyisocyanate, 10-15 parts of emulsifier, 4-6 parts of dispersant, 5-7 parts of polyvinyl alcohol, 1-2 parts of chitosan oligosaccharide, 2.5-5 parts of diethylenetriamine, 75-85 parts of solvent, and 800-1000 parts of water.

[0012] Microencapsulation technology, as an important form of sustained-release formulation, can effectively protect and precisely release active ingredients, while also improving their physicochemical stability to a certain extent, reducing adverse effects such as photolysis, oxidation, hydrolysis, and microbial degradation, and ensuring the content of effective active ingredients. This invention employs interfacial polymerization, using co-crystalline propionyl brassinolide and triacontanol as core materials. After emulsification, the two monomers migrate to the oil-water interface and undergo condensation polymerization, forming a polymer shell on the droplet surface. Based on the aforementioned co-crystalline morphology of propionyl brassinolide, this invention enables the two active ingredients to achieve molecular-level uniform mixing within the microcapsule, significantly improving the bioavailability of the active ingredients and effectively avoiding defects such as aggregation, Auschwitz ripening, and stratification.

[0013] Further, the emulsifier is selected from one or more of TO-8, TO-7, TO-10, TO-12, and AEO-9; the dispersant is selected from one or more of SC001, polycarboxylate, and lignin sulfonate; the thickener is selected from one or more of xanthan gum, guar gum, and gum arabic; and the preservative is selected from one or more of Kathon, BIT, sodium benzoate, and parabens.

[0014] Furthermore, the additive is one or more of organosilicon, fatty alcohol, and polyether defoamer; the diluent is water.

[0015] This invention also provides a method for preparing a 0.1% propanetriol-triaconitine suspension, comprising the following steps: Diluent, thickener, preservative, and some adjuvants are added sequentially to a container, and the mixture is sheared at high speed to form a homogeneous liquid. Then, the active ingredient propanetriol triacontanol, emulsifier, and dispersant are slowly added to the homogeneous liquid, and the mixture is sheared continuously until homogeneous. The remaining adjuvants are added after cooling, and the mixture is stirred evenly to obtain a suspension.

[0016] Furthermore, the suspending agent needs to be adjusted to pH 5-6.5, and the pH adjuster used is citric acid or sodium citrate.

[0017] This invention also provides an application of 0.1% propanetriol-triaconitine suspension in the cultivation of fruits, field crops, and cash crops. When using it, it should be diluted 1000-3000 times and sprayed directly.

[0018] Compared with the prior art, the beneficial effects of the present invention are: This invention optimizes the types and ratios of raw materials to prepare a 0.1% propionyl brassinolide-triacontanol microcapsule suspension using co-crystalline propionyl brassinolide and triacontanol technical grade microcapsules. This not only fully utilizes the complementary advantages of propionyl brassinolide and triacontanol, but also achieves dual physical and chemical stability in the resulting microcapsule suspension. On the one hand, it maximizes the efficacy of the technical grade drug and improves bioavailability; on the other hand, it significantly improves the stability of the technical grade drug, reduces defects such as decomposition and stratification, and significantly extends the duration of efficacy and effective storage period. Detailed Implementation

[0019] To make the objectives, technical solutions, and advantages of this invention clearer, the technical solutions of this invention will be clearly and completely described below in conjunction with embodiments. Where specific conditions are not specified in the embodiments, conventional conditions or conditions recommended by the manufacturer shall apply. Reagents or instruments whose manufacturers are not specified are all conventional products that can be purchased commercially.

[0020] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. The terminology used in this specification is for the purpose of describing particular embodiments only and is not intended to limit the invention. The term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.

[0021] Example 1 A method for preparing a 0.1% propargyl triacontanol suspension includes the following steps: 1. Weigh 10 parts of propionyl brassinolide and 14 parts of nicotinamide, add to 80 parts of anhydrous ethanol, heat to 35℃ and stir at 400 rpm for 15 min, then cool to 12℃ to slowly precipitate solid, wash and dry to obtain cocrystal propionyl brassinolide.

[0022] 2. Weigh 0.03 parts of cocrystalline propionyl brassinolide and 0.97 parts of triacontanol, mix with 9 parts of isophorone diisocyanate, and add to 80 parts of anhydrous ethanol. Heat to 45°C and stir until homogeneous to obtain the oil phase. Separately, add 12 parts of Tween 80, 5 parts of sodium lignosulfonate, 6 parts of polyvinyl alcohol, and 1.5 parts of chitosan oligosaccharide to 900 parts of water and stir until homogeneous to obtain the aqueous phase. Slowly drop the oil phase into the aqueous phase and emulsify by high-speed shearing (8000 rpm, 20 min) to obtain the primary emulsion. Slowly add 3.5 parts of diethylenetriamine to the primary emulsion, heat to 50°C and react at 500 rpm for 3 h. After the reaction, heat to 60°C and solidify for 1 h. Centrifuge, wash, and dry to obtain propionyl brassinolide-triacontanol microcapsules.

[0023] 3. Weigh out 0.1 parts by weight of propanetriol-triacontanol microcapsules, 2.0 parts by weight of TO-8, 8 parts by weight of SC001, 0.2 parts by weight of xanthan gum, 0.2 parts by weight of BIT, 0.06 parts by weight of polydimethylsiloxane, with the remainder being water. Add water, xanthan gum, BIT, and 1 / 2 part by weight of polydimethylsiloxane sequentially to the reactor. Perform high-speed shearing (6000 rpm, 15 min) to form a homogeneous liquid. Then, slowly add propanetriol-triacontanol microcapsules, TO-8, and SC001 to the homogeneous liquid, and continue shearing (400 rpm, 60 min) until uniform. Finally, cool to room temperature, add the remaining polydimethylsiloxane, and then add sodium citrate to adjust the pH to 6.0. Stir until homogeneous to obtain the suspension product.

[0024] Example 2 A method for preparing a 0.1% propargyl triacontanol suspension includes the following steps: 1. Weigh 10 parts of propionyl brassinolide and 12 parts of nicotinamide, add to 80 parts of anhydrous ethanol, heat to 30℃ and stir at 400 rpm for 15 min, then cool to 10℃ to slowly precipitate solid, wash and dry to obtain cocrystal propionyl brassinolide.

[0025] 2. Weigh 0.02 parts of cocrystalline propionyl brassinolide and 0.98 parts of triacontanol, mix with 8 parts of isophorone diisocyanate, and add to 75 parts of anhydrous ethanol. Heat to 45°C and stir until homogeneous to obtain the oil phase. Separately, add 10 parts of Tween 80, 4 parts of sodium lignosulfonate, 5 parts of polyvinyl alcohol, and 1 part of chitosan oligosaccharide to 800 parts of water and stir until homogeneous to obtain the aqueous phase. Slowly drop the oil phase into the aqueous phase and emulsify by high-speed shearing (8000 rpm, 20 min) to obtain the primary emulsion. Slowly add 2.5 parts of diethylenetriamine to the primary emulsion, heat to 50°C and react at 500 rpm for 3 h. After the reaction, heat to 60°C and solidify for 1 h. Centrifuge, wash, and dry to obtain propionyl brassinolide-triacontanol microcapsules.

[0026] 3. Weigh out 0.1 parts by weight of propanetriol-triacontanol microcapsules, 1.5 parts by weight of TO-8, 6 parts by weight of SC001, 0.1 parts by weight of xanthan gum, 0.1 parts by weight of BIT, 0.04 parts by weight of polydimethylsiloxane, with the remainder being water. Add water, xanthan gum, BIT, and 1 / 2 part by weight of polydimethylsiloxane sequentially to the reactor. Perform high-speed shearing (6000 rpm, 15 min) to form a homogeneous liquid. Then, slowly add propanetriol-triacontanol microcapsules, TO-8, and SC001 to the homogeneous liquid, and continue shearing (400 rpm, 60 min) until uniform. Finally, cool to room temperature, add the remaining polydimethylsiloxane, and then add sodium citrate to adjust the pH to 5.5. Stir until homogeneous to obtain the suspension product.

[0027] Example 3 A method for preparing a 0.1% propargyl triacontanol suspension includes the following steps: 1. Weigh 10 parts of propionyl brassinolide and 15 parts of nicotinamide, add to 80 parts of anhydrous ethanol, heat to 35℃ and stir at 400 rpm for 15 min, then cool to 12℃ to slowly precipitate solid, wash and dry to obtain cocrystal propionyl brassinolide.

[0028] 2. Weigh 0.05 parts of cocrystalline propionyl brassinolide and 0.95 parts of triacontanol, mix with 10 parts of isophorone diisocyanate, and add to 85 parts of anhydrous ethanol. Heat to 45°C and stir until homogeneous to obtain the oil phase. Separately, add 15 parts of Tween 80, 6 parts of sodium lignosulfonate, 7 parts of polyvinyl alcohol, and 2 parts of chitosan oligosaccharide to 1000 parts of water and stir until homogeneous to obtain the aqueous phase. Slowly drop the oil phase into the aqueous phase and emulsify by high-speed shearing (8000 rpm, 20 min) to obtain the primary emulsion. Slowly add 5 parts of diethylenetriamine to the primary emulsion, heat to 50°C and react at 500 rpm for 3 h. After the reaction is completed, heat to 60°C and solidify for 1 h. Centrifuge, wash, and dry to obtain propionyl brassinolide-triacontanol microcapsules.

[0029] 3. Weigh out 0.1 parts by weight of propanetriol-triacontanol microcapsules, 2.5 parts by weight of TO-8, 10 parts by weight of SC001, 0.3 parts by weight of xanthan gum, 0.3 parts by weight of BIT, 0.1 parts by weight of polydimethylsiloxane, with the remainder being water. Add water, xanthan gum, BIT, and 1 / 2 part by weight of polydimethylsiloxane sequentially to the reactor. Perform high-speed shearing (6000 rpm, 15 min) to form a homogeneous liquid. Then, slowly add propanetriol-triacontanol microcapsules, TO-8, and SC001 to the homogeneous liquid, and continue shearing (400 rpm, 60 min) until uniform. Finally, cool to room temperature, add the remaining polydimethylsiloxane, and then add sodium citrate to adjust the pH to 6.5. Stir until homogeneous to obtain the suspension product.

[0030] Comparative Example 1 A 0.1% propargyl brassinolide-triacontanol suspension differs from Example 1 only in that it does not undergo co-crystallization treatment: in step 2, 0.03 parts of propionyl brassinolide are used instead of co-crystallized propionyl brassinolide to prepare propargyl brassinolide-triacontanol microcapsules.

[0031] Comparative Example 2 A 0.1% propionyl brassinolide-triacontanol suspension differs from Example 1 only in that it is prepared directly as a suspension without microencapsulation: 0.003 parts by weight of co-crystalline propionyl brassinolide, 0.097 parts by weight of triacontanol, 2.0 parts by weight of TO-8, 8 parts by weight of SC001, 0.2 parts by weight of xanthan gum, 0.2 parts by weight of BIT, 0.06 parts by weight of polydimethylsiloxane, 10 parts by weight of anhydrous ethanol, and the remainder being water. The preparation method is as follows: Eutectic propionyl brassinolide was dissolved in anhydrous ethanol to obtain a homogeneous liquid; water, triacontanol, SC001, xanthan gum, BIT, and polydimethylsiloxane were added sequentially to the reaction vessel and stirred until homogeneous; the homogeneous liquid was slowly pumped into the reaction vessel under continuous stirring and stirred until homogeneous; finally, the suspension product was obtained by sand milling.

[0032] Comparative Example 3 A 0.1% propargyl brassinolide-triacontanol suspension, based on Comparative Example 2, uses propionyl brassinolide instead of cocrystallized propionyl brassinolide.

[0033] Test Example 1: Stability Test The storage stability of the suspension samples prepared in the above examples and comparative examples was tested, and the results are shown in Table 1 (testing was conducted according to GB / T 19136-2021).

[0034] Table 1 Stability test results

[0035] As shown in Table 1, the microcapsule suspension prepared in the embodiments of the present invention exhibits excellent storage stability, maintaining a high content of active ingredients even under prolonged ultraviolet light irradiation or high temperature conditions. Compared with traditional suspensions, the photolysis and pyrolysis rates are significantly reduced, effectively extending the efficacy and shelf life. However, comparing the data from Comparative Example 1, it can be seen that propionyl brassinolide, despite the protective effect of the microcapsules, exhibits significantly reduced photostability and slightly reduced thermal stability, even without eutectic treatment. Comparing the data from Comparative Examples 2 and 3, it can be seen that the lack of microcapsule protection leads to a significant reduction in the photothermal stability of the suspension, resulting in obvious aggregation and stratification defects after storage under different conditions.

[0036] Experiment Example 2: Chili Pepper Growth Experiment The suspension samples prepared using the above-described embodiments and comparative examples were sprayed on the leaves of chili peppers, and the effects on subsequent growth were compared and analyzed.

[0037] Experimental crop: Hangzhou pepper; Test location: Chili greenhouse in Liming Village, Dangyang City, Yichang City, Hubei Province; Community allocation: Each community to be processed has an area of ​​20 square meters; Application method: Spray the entire plant with water.

[0038] The dosage was 3 mL / m² (dilution ratios of 1500 and 3000), diluted and sprayed evenly onto the chili plants. An equal volume of water was sprayed as a control. The application was conducted on a sunny, windless day with outdoor temperatures of 19-24℃ and indoor temperatures of 22-25℃, with no significant factors affecting the efficacy of the pesticide. After application, normal chili cultivation management practices were followed.

[0039] Fifteen plants of similar growth were randomly selected from each treatment plot. Nine days after application, a survey was conducted. The length of the first branch from the bottom up was measured for each plant, and the overall plant height was measured vertically from the ground to the top of the plant's growing point. The results are as follows: Table 2. Results of chili pepper growth survey 9 days after application of pesticide.

[0040] As shown in Table 2, the microcapsule suspension prepared according to the embodiments of the present invention can effectively promote the growth of peppers, with a significant increase in plant height and rapid branch extension. Compared with the CK group, the increase is significantly higher, proving that the microcapsule suspension of the present invention has a significant effect on promoting pepper growth. However, comparing the data of Comparative Example 1, it can be seen that the growth-promoting effect of the microcapsule suspension prepared using propionyl brassinolide without co-crystallization treatment is significantly reduced, possibly because the active ingredients are not mixed evenly, resulting in a decrease in bioavailability. Comparing the data of Comparative Examples 2 and 3, it can be seen that the suspension without microcapsule protection has no sustained-release effect, and the degradation and decomposition rate of the active ingredients is too fast, and the promoting effect is similar to that of the CK group after a short period of time.

[0041] After the chili pepper samples from each experimental group matured, chili peppers of similar size and with as uniform color as possible were harvested from each treatment plot for the detection of capsaicin-like substances (using high-performance liquid chromatography, according to GB / T21266). (External standard method, 2007) The results are as follows: Table 3. Test results of capsaicin content in mature samples

[0042] As shown in Table 3, the application of the microcapsule suspension prepared in the embodiments of the present invention can effectively increase the content of capsaicin in Hangzhou peppers, especially the content of dihydrocapsaicin, which is significantly increased compared with the CK group. In addition, the present invention can also extend the shelf life of fresh peppers, ensure the high content of key capsaicin components, and improve product quality. Although the capsaicin content of fresh peppers in Comparative Example 1 decreased only slightly after harvesting, the content of dihydrocapsaicin decreased significantly after a certain period of storage. In Comparative Examples 2 and 3, both the capsaicin content of fresh peppers and the retention rate after storage decreased significantly, resulting in poor quality.

[0043] The embodiments described above are merely preferred embodiments of the present invention, and while the descriptions are specific and detailed, they are not intended to limit the present invention. It should be noted that various changes and modifications can be made to the present invention by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the concept and principles of the present invention should be included within the scope of protection of the present invention.

Claims

1. A 0.1% propargyl triacontanol suspension, characterized in that, Based on 100 parts by weight, the ingredients include the following: 0.09-0.11 parts of technical grade drug, 1.5-2.5 parts of emulsifier, 6-10 parts of dispersant, 0.1-0.3 parts of thickener, 0.1-0.3 parts of preservative, 0.04-0.1 parts of adjuvant, and the balance is diluent; The active ingredient is propionyl brassinolide and triacontanol, specifically prepared by cocrystallized propionyl brassinolide and triacontanol in a mass ratio of (2-5):(95-98).

2. The 0.1% propanetriol-triaconitine suspension according to claim 1, characterized in that, The cocrystallized propionyl brassinolide uses nicotinamide as the cocrystallized ligand. The cocrystallization preparation method is as follows: dissolve propionyl brassinolide and nicotinamide in anhydrous ethanol, heat and stir until homogeneous, then cool and crystallize to obtain a solid, wash and dry to obtain cocrystallized propionyl brassinolide.

3. The 0.1% propanetriol-triaconitine suspension according to claim 2, characterized in that, The mass ratio of propionyl brassinolide to nicotinamide is 1:(1.2-1.5); the heating and stirring temperature is 30-35℃, the stirring speed is 300-500rpm, and the time is 10-20 min; the cooling and crystallization temperature is 10-12℃.

4. The 0.1% propanetriol-triaconitine suspension according to claim 1, characterized in that, The propargyl brassinolide and triacontanol also need to be pre-prepared into microcapsules: weigh co-crystalline propionyl brassinolide and triacontanol according to the formula, mix with polyisocyanate and add to solvent, heat and stir evenly to form the oil phase; separately add emulsifier, dispersant, polyvinyl alcohol and chitosan oligosaccharide to water in sequence, stir evenly to form the aqueous phase; slowly drip the oil phase into the aqueous phase, emulsify by high-speed shearing to obtain the primary emulsion; slowly add diethylenetriamine to the primary emulsion, polymerize at controlled temperature, solidify after the reaction is completed, separate, wash and dry to obtain propargyl brassinolide and triacontanol microcapsules.

5. The 0.1% propanetriol-triaconitine suspension according to claim 4, characterized in that, The raw materials used in the microcapsules are as follows by weight: 1 part of cocrystallized brassinolide and triacontanol, 8-10 parts of polyisocyanate, 10-15 parts of emulsifier, 4-6 parts of dispersant, 5-7 parts of polyvinyl alcohol, 1-2 parts of chitosan oligosaccharide, 2.5-5 parts of diethylenetriamine, 75-85 parts of solvent, and 800-1000 parts of water.

6. The 0.1% propanetriol-triaconitine suspension according to claim 1, characterized in that, The emulsifier is selected from one or more of TO-8, TO-7, TO-10, TO-12, and AEO-9; the dispersant is selected from one or more of SC001, polycarboxylate, and lignin sulfonate; the thickener is selected from one or more of xanthan gum, guar gum, and gum arabic; and the preservative is selected from one or more of Kathon, BIT, sodium benzoate, and parabens.

7. The 0.1% propanetriol-triaconitine suspension according to claim 1, characterized in that, The additive is one or more of organosilicon, fatty alcohol, and polyether defoamer; the diluent is water.

8. A method for preparing a 0.1% propanetriol-triaconitine suspension according to any one of claims 1-7, characterized in that, Includes the following steps: Diluent, thickener, preservative, and some adjuvants are added sequentially to a container, and the mixture is sheared at high speed to form a homogeneous liquid. Then, the active ingredient propanetriol triacontanol, emulsifier, and dispersant are slowly added to the homogeneous liquid, and the mixture is sheared continuously until homogeneous. The remaining adjuvants are added after cooling, and the mixture is stirred evenly to obtain a suspension.

9. The method for preparing a 0.1% propanetriol-triaconitine suspension according to claim 8, characterized in that, The suspending agent also needs to be adjusted to pH 5-6.5, and the pH adjuster used is citric acid or sodium citrate.

10. The application of a 0.1% propargyl triacontanol suspension concentrate according to any one of claims 1-7 in the cultivation of fruits, field crops, and cash crops, characterized in that, Dilute 1000-3000 times and spray directly.